Talazoparib versus chemotherapy in patients with germline BRCA1/2-mutated HER2-negative advanced breast cancer: final overall survival results from the EMBRACA trial
Litton, J.K., Hurvitz, S.A., Mina, L.A., Rugo, H.S., Lee, K.-H., Gonçalves, A., Diab, S., Woodward, N., Goodwin, A., Yerushalmi, R., Roché, H., Im, Y.-H., Eiermann, W., Quek, R.G.W., Usari, T., Lanzalone, S., Czibere, A., Blum, J.L., Martin, M., Ettl, J.
Published in Annals of oncology (01.11.2020)
Published in Annals of oncology (01.11.2020)
Get full text
Journal Article
Quality of life with talazoparib versus physician’s choice of chemotherapy in patients with advanced breast cancer and germline BRCA1/2 mutation: patient-reported outcomes from the EMBRACA phase III trial
Ettl, J., Quek, R.G.W., Lee, K.-H., Rugo, H.S., Hurvitz, S., Gonçalves, A., Fehrenbacher, L., Yerushalmi, R., Mina, L.A., Martin, M., Roché, H., Im, Y.-H., Markova, D., Bhattacharyya, H., Hannah, A.L., Eiermann, W., Blum, J.L., Litton, J.K.
Published in Annals of oncology (01.09.2018)
Published in Annals of oncology (01.09.2018)
Get full text
Journal Article
Determinants of Response to Talazoparib in Patients with HER2-Negative, Germline BRCA1/2-Mutated Breast Cancer
Blum, Joanne L, Laird, A Douglas, Litton, Jennifer K, Rugo, Hope S, Ettl, Johannes, Hurvitz, Sara A, Martin, Miguel, Roché, Henri H, Lee, Kyung-Hun, Goodwin, Annabel, Chen, Ying, Lanzalone, Silvana, Chelliserry, Jijumon, Czibere, Akos, Hopkins, Julia F, Albacker, Lee A, Mina, Lida A
Published in Clinical cancer research (01.04.2022)
Published in Clinical cancer research (01.04.2022)
Get full text
Journal Article
The importance of jointly analyzing treatment administration and toxicity associated with targeted therapies: a case study of regorafenib in soft tissue sarcoma patients
Longué, M., Cabarrou, B., Wallet, J., Brodowicz, T., Roché, H., Boher, J.M., Delord, J.P., Penel, N., Filleron, T.
Published in Annals of oncology (01.07.2018)
Published in Annals of oncology (01.07.2018)
Get full text
Journal Article
Methodology of phase II clinical trials in metastatic elderly breast cancer: a literature review
Cabarrou, B., Mourey, L., Dalenc, F., Balardy, L., Kanoun, D., Roché, H., Boher, J. M., Rougé-Bugat, M. E., Filleron, Thomas
Published in Breast cancer research and treatment (01.08.2017)
Published in Breast cancer research and treatment (01.08.2017)
Get full text
Journal Article
How to report toxicity associated with targeted therapies?
Cabarrou, B., Boher, J.M., Bogart, E., Tresch-Bruneel, E., Penel, N., Ravaud, A., Escudier, B., Mahier Ait-Oukhatar, C., Delord, J.P., Roché, H., Filleron, T.
Published in Annals of oncology (01.08.2016)
Published in Annals of oncology (01.08.2016)
Get full text
Journal Article
Long-term cardiac toxicity after adjuvant epirubicin-based chemotherapy in early breast cancer: French Adjuvant Study Group Results
Fumoleau, P., Roché, H., Kerbrat, P., Bonneterre, J., Romestaing, P., Fargeot, P., Namer, M., Monnier, A., Montcuquet, P., Goudier, M.-J., Luporsi, E.
Published in Annals of oncology (01.01.2006)
Published in Annals of oncology (01.01.2006)
Get full text
Journal Article
Choosing a career in oncology: results of a nationwide cross-sectional study
Faivre, J C, Bibault, J E, Bellesoeur, A, Salleron, J, Wack, M, Biau, J, Cervellera, M, Janoray, G, Leroy, T, Lescut, N, Martin, V, Molina, S, Pichon, B, Teyssier, C, Thureau, S, Mazeron, J J, Roché, H, Culine, S
Published in BMC medical education (15.01.2018)
Published in BMC medical education (15.01.2018)
Get full text
Journal Article
UNICANCER-PEGASE 07 study: a randomized phase III trial evaluating postoperative docetaxel–5FU regimen after neoadjuvant dose-intense chemotherapy for treatment of inflammatory breast cancer
Gonçalves, A., Pierga, J.-Y., Ferrero, J.-M., Mouret-Reynier, M.-A., Bachelot, T., Delva, R., Fabbro, M., Lerebours, F., Lotz, J.-P., Linassier, C., Dohollou, N., Eymard, J.-C., Leduc, B., Lemonnier, J., Martin, A.-L., Boher, J.-M., Viens, P., Roché, H.
Published in Annals of oncology (01.08.2015)
Published in Annals of oncology (01.08.2015)
Get full text
Journal Article
Analysis of overall survival from a phase III study of ixabepilone plus capecitabine versus capecitabine in patients with MBC resistant to anthracyclines and taxanes
Hortobagyi, Gabriel N, Gomez, Henry L, Li, Rubi K, Chung, Hyun-Cheol, Fein, Luis E, Chan, Valorie F, Jassem, Jacek, Lerzo, Guillermo L, Pivot, Xavier B, Hurtado de Mendoza, Fernando, Xu, Binghe, Vahdat, Linda T, Peck, Ronald A, Mukhopadhyay, Pralay, Roché, Henri H
Published in Breast cancer research and treatment (01.07.2010)
Published in Breast cancer research and treatment (01.07.2010)
Get full text
Journal Article
Docetaxel vs 5-fluorouracil plus vinorelbine in metastatic breast cancer after anthracycline therapy failure
BONNETERRE, J, ROCHE, H, MONNIER, A, GUASTALLA, J. P, NAMER, M, FARGEOT, P, ASSADOURIAN, S
Published in British journal of cancer (18.11.2002)
Published in British journal of cancer (18.11.2002)
Get full text
Journal Article
Ixabepilone-associated peripheral neuropathy: data from across the phase II and III clinical trials
Vahdat, Linda T., Thomas, Eva S., Roché, Henri H., Hortobagyi, Gabriel N., Sparano, Joseph A., Yelle, Louise, Fornier, Monica N., Martín, Miguel, Bunnell, Craig A., Mukhopadhyay, Pralay, Peck, Ronald A., Perez, Edith A.
Published in Supportive care in cancer (01.11.2012)
Published in Supportive care in cancer (01.11.2012)
Get full text
Journal Article
Secondary leukemia after epirubicin-based adjuvant chemotherapy in operable breast cancer patients: 16 years experience of the French Adjuvant Study Group
Campone, M., Roché, H., Kerbrat, P., Bonneterre, J., Romestaing, P., Fargeot, P., Namer, M., Monnier, A., Montcuquet, P., Goudier, M.-J., Fumoleau, P.
Published in Annals of oncology (01.08.2005)
Published in Annals of oncology (01.08.2005)
Get full text
Journal Article
Chemotherapy (CT) decision in node-positive (N+), ER+, early breast cancer (EBC) after new ASCO Guideline – evidence for the 21-gene Recurrence Score (RS) assay
Mamounas, E.P, Goldstein, L.J, Penault-Llorca, F, Roché, H, Gluz, O, Harbeck, N, Nitz, U, O’shaughnessy, J, Albain, K.S
Published in Breast (Edinburgh) (01.03.2017)
Published in Breast (Edinburgh) (01.03.2017)
Get full text
Journal Article
Activity of ixabepilone in oestrogen receptor-negative and oestrogen receptor-progesterone receptor-human epidermal growth factor receptor 2-negative metastatic breast cancer
Pivot, Xavier B, Li, Rubi K, Thomas, Eva S, Chung, Hyun-Cheol, Fein, Luis E, Chan, Valorie F, Jassem, Jacek, Mendoza, Fernando Hurtado de, Mukhopadyay, Pralay, Roché, Henri H
Published in European journal of cancer (1990) (01.11.2009)
Published in European journal of cancer (1990) (01.11.2009)
Get full text
Journal Article
Improved disease-free survival with epirubicin-based chemoendocrine adjuvant therapy compared with tamoxifen alone in one to three node-positive, estrogen-receptor-positive, postmenopausal breast cancer patients: results of French Adjuvant Study Group 02 and 07 trials
Namer, M., Fargeot, P., Roché, H., Campone, M., Kerbrat, P., Romestaing, P., Monnier, A., Luporsi, E., Montcuquet, P., Bonneterre, J.
Published in Annals of oncology (01.01.2006)
Published in Annals of oncology (01.01.2006)
Get full text
Journal Article
Ixabepilone Plus Capecitabine for Metastatic Breast Cancer Progressing After Anthracycline and Taxane Treatment
THOMAS, Eva S, GOMEZ, Henry L, BINGHE XU, CAMPONE, Mario, LERZO, Guillermo L, PECK, Ronald A, MUKHOPADHYAY, Pralay, VAHDAT, Linda T, ROCHE, Henri H, LI, Rubi K, CHUNG, Hyun-Cheol, FEIN, Luis E, CHAN, Valorie F, JASSEM, Jacek, PIVOT, Xavier B, KLIMOVSKY, Judith V, HURTADO DE MENDOZA, Fernando
Published in Journal of clinical oncology (20.11.2007)
Published in Journal of clinical oncology (20.11.2007)
Get full text
Journal Article